Almost 20 biopharma and life sciences companies have registered to lobby on a bill that could ban US companies from working with Chinese life sciences contractors, according to federal records.
WuXi Biologics Reports Solid 2023 Annual Results
WuXi Biologics touted its partnerships and contracts in its annual report on Tuesday, noting that it has almost 700 projects in its pipeline, which can help supply the service provider with security.
Biotech trade association to split with China`s WuXi AppTec
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment
It doesn’t take a lot to disrupt a relationship between a biopharma company and a global CRO/CDMO. From the smallest startup shepherding a single drug into the clinic to a major pharma player looking for substantial outside help in R&D and manufacturing, these contractual alliances run for years, with enormous stakes on long-term projects.
WuXi AppTec, Wuxi Biologics plunge to multi-year lows on fears over biotech bill
WuXi Biologics Successfully Completes First 16,000L Manufacturing Run in Ireland
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.